Skip to main content

HEALTH

  • WSJ: J&J shopping women's care unit

    NEW YORK — Johnson & Johnson is shopping its women's health unit, according to a report Friday in The Wall Street Journal, which suggested that the business no longer coincided with J&J's "growth priorities." 

    The brands managed by the unit include intimacy health KY and women's personal care brands, o.b. tampons and Stayfree and Carefree pads. 

  • FDA approves three new drugs for Type 2 diabetes

    SILVER SPRING, Md. — The Food and Drug Administration has approved three new drugs for Type 2 diabetes made by Takeda, the agency said Friday.

    The FDA announced the approval of Nesina (alogliptin), Kazano (alogliptin and metformin) and Oseni (alogliptin and pioglitazone) tablets.

    Alogliptin is a new active ingredient, while metformin and pioglitazone are drugs already on the market.

  • Carmex contestant drains half-court shot, wins $75,000 and gets tackled by LeBron James

    MIAMI — In a shot that made the rounds Friday on ESPN and other sports shows, Miami Heat fan Michael Drysch drained a half-court shot in the Carmex Half-Court Hero contest, netting $75,000 and getting tackled by Miami Heat superstar LeBron James. 

    In addition to winning $75,000 for himself, Drysch also scored a $75,000 donation for the Boys & Girls Clubs of America and the Lebron James Family Foundation.

  • Perrigo introduces new packaging for infant formula

    GEORGIA, Vt. — Perrigo Nutritionals is introducing new packaging that the company said would make providing nutrition to infants more convenient.

  • Wellco Brands launches pain relief cream for under the nose of cold, allergy sufferers

    BUFFALO, N.Y. — Wellco Brands on Thursday launched Healerz for Noses, a pain relief cream to soothe the skin under the nose that becomes irritated during cold and allergy season.  

    Healerz is formulated with lidocaine for pain relief, benzalkonium chloride antiseptic to help guard against infection and aloe for its soothing properties.  

    Each package contains six single-use packets.

  • Johns Hopkins researchers track flu through Twitter

    BALTIMORE — "Too sick to go to work, but not sick enough not to tweet about it" Twitter users are helping to predict flu trends. Johns Hopkins researchers recently created a Twitter search method that helps differentiate between people merely tweeting about the flu in general and those who are actually sick, the university announced Thursday. The new tweet-screening method not only delivers real-time data on flu cases, but also filters out online chatter that is not linked to actual flu infections. 

  • CDC: Flu still strong across central U.S.

    ATLANTA — If the flu were a storm cloud, the influenza virus is hovering over America's Bread Basket on its way to the Southwest, according to data provided through the U.S. Outpatient Influenza-like Illness Surveillance Network. 

    The Centers for Disease Control and Prevention on Friday reported that 4.3% of patient visits reported through ILINet were due to influenza-like illness, above the national baseline of 2.2%. But as the map indicates, influenza rates are declining up and down the East Coast and is most virulent in Texas and states west.

  • Merck: FDA approves Oxytrol for Women, creating overactive bladder category in OTC

    WHITEHOUSE STATION, N.J. — Merck on Friday announced the Food and Drug Administration has approved the switch of Oxytrol for Women (oxybutynin transdermal system, 3.9 mg/day) from prescription-only to nonprescription, creating a new category — overactive bladder in women — in the OTC area. Most notable about this switch is the fact that the FDA approved Oxytrol for Women against the majority opinion of its Nonprescription Drug Advisory Committee, which voted five in favor and six opposed to the switch in November. 

X
This ad will auto-close in 10 seconds